Login / Signup

The OPAT opportunity for beta-lactam individualization.

Lindsey M Childs-KeanChristina G RiveraVeena VenugopalanMadelyn J JohnsonErin F Barreto
Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2024)
Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral antimicrobial therapy requires careful consideration of potential logistical and therapeutic barriers.
Keyphrases
  • acute care
  • gram negative
  • risk factors
  • staphylococcus aureus
  • stem cells
  • emergency department
  • climate change
  • mesenchymal stem cells
  • bone marrow
  • adverse drug